Mycobacterium tuberculosis Inactivation

Authors
Dr. Roopa Viswanathan, Study Director
Facility
Qualilife Diagnostics
Download
Full Report

Objective

To evaluate the efficacy of the Protect 200 on reducing Mycobacterium tuberculosis.

Methodology

The Protect 200 unit was placed inside a 68 litre plastic enclosure. The plastic enclosure and test set up was placed inside a biosafety cabinet. Clinical isolate of Mycobacterium tuberculosis was aseptically transferred into a sterile mycobacteria growth indicator tube (MGIT) and Lowenstein-Jensen (LJ) medium.

Summary of Results

The air sample collected from the test after being exposed to the Protect 200 showed no growth of Mycobacterium tuberculosis. This shows that the device has effectively rendered all airborne Mycobacterium tuberculosis non-viable.

Subscribe to our newsletter

Get news and updates about our latest products and offerings

Social

Partners